Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New dye could spare DCIS patients from unnecessary lymph node surgery

NCT ID NCT06868238

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times

Summary

This study is for people with non-invasive breast cancer (DCIS) who are having a mastectomy. Normally, surgeons remove lymph nodes at the same time, but most of these removals are unnecessary. The study uses a special iron-based dye called Magtrace that stays in the lymph nodes for weeks, allowing doctors to remove them later only if invasive cancer is found. The goal is to see if this approach can safely avoid unnecessary lymph node surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32608, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.